COVID-2019 Alert

The latest information about the 2019 Novel Coronavirus, including vaccine clinics for 12-17 year-olds.

La información más reciente sobre el nuevo Coronavirus de 2019, incluidas las clínicas de vacunación para jóvenes de 12 a 17 años.

  • Drs. Porter and Grant Discuss ResearchDrs. Porter and Grant Discuss Research

Tuberous Sclerosis Complex (TSC)

US News - Stanford Children's HealthTSC is a disorder in which a genetic abnormality causes growths to form in organ systems throughout the body, including the brain, kidney, eyes, skin, heart and lungs. These noncancerous growths can create serious health issues by interfering with the function of these organs. In children, symptoms can often include intellectual disability, seizuresepilepsy and developmental delay.

Why come to Stanford Children’s Health for the diagnosis and treatment of TSC?

Because TSC is a complex disease with so many potential symptoms, its diagnosis and treatment requires specialized expertise. We are home to a multidisciplinary team of experts who have the experience needed to develop and implement the best possible care plan for your child, including managing mTOR inhibitors, one of the most effective treatments for TSC. Led by Brenda Porter, MD, this team includes world-class neurologists, nephrologists, ophthalmologistsdermatologists and pulmonologists. These specialists will work together with each other and with the family to reach the best possible outcome.

We are proud to be one of only two official TSC Alliance–recognized clinics in Northern California. We are also part of the Tuberous Sclerosis Research Alliance, a coalition of centers around the country that are leading the charge in the research and treatment of the disease.

Finally, because of our affiliation with Stanford Health Care, patients can expect continuity of care as they transition into adulthood.